“…The interest in topoisomerase I as a therapeutic target promoted various efforts to identify other chemotypes effective as topoisomerase inhibitors and chemical/modelling efforts to rationally design specific analogs among known inhibitors [8,9,10,11] . During the last years several tetra-and pentacyclic structures containing the indoline fragment has received much attention due to the structural correlation with natural compounds belonging to the alkaloids class endowed with biological activity as cyclooxygenase/5-lipooxygenase inhibitors, characterized by the presence of the pyrrolo[3,2-de]acridine subunit [12] , indolocarbazoles non-CPT topo I inhibitors [13,14,15,16] and analogues of physostigmine alkaloids [17,18,19,20] .…”